Profitability improved sharply as the health benefits ratio declined
GAAP diluted EPS was $2.19 in Q2 FY2026, compared with a loss of $0.51 per share in Q2 2025. The health benefits ratio improved to 89.6% from 93.0%, aided by improved Marketplace pricing and risk transfers, Medicaid rate and revenue increases, medical-cost management, and the absence of a Medicare Advantage premium-deficiency reserve in 2026.
Revenue growth was led by premium taxes, PDP growth, rate actions, and state-directed payments
Total revenue increased 10% to $53.6B, while premium and service revenue increased 4% to $44.4B. Management attributed the increase primarily to state pass-through premium taxes, higher premium yield and membership growth in Medicare Part D PDPs, Marketplace and Medicaid rate increases, Marketplace risk-adjustment transfers, and state-directed payments; lower Marketplace and Medicaid membership partly offset these drivers.
Commercial profitability strengthened despite a sizable Marketplace membership decline
Commercial revenue declined 7% to $9.4B, primarily because Marketplace membership fell, but Commercial gross margin more than doubled to $1.9B from $946M. Management cited rate increases, its 2026 risk-adjustment transfer estimate, and the final 2025 risk-adjustment transfer, including a stated $481M pre-tax benefit after related offsets, as key contributors.